Stocktoria
Medtronic plc MDT
NYSE · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1977-11-21
Medtronic plc financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B | $30.1B | $28.9B | $30.6B | $30.0B | $29.7B |
| Gross profit | — | — | — | — | — | — | — | — | $20.9B | $20.4B |
| SG&A expense | $11.8B | $10.8B | $10.7B | $10.4B | $10.3B | $10.1B | $10.1B | $10.4B | $10.2B | $10.0B |
| Operating income | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B | $4.5B | $4.8B | $6.3B | $6.6B | $5.4B |
| Interest expense | — | — | $719.0M | $636.0M | $553.0M | $925.0M | $1.1B | $1.4B | $1.1B | $1.1B |
| Income tax | $1.3B | $936.0M | $1.1B | $1.6B | $456.0M | $265.0M | -$751.0M | $547.0M | $2.6B | $578.0M |
| Net income | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B | $3.6B | $4.8B | $4.6B | $3.1B | $4.0B |
| EPS (diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 |
| Operating cash flow | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B | $6.2B | $7.2B | $7.0B | $4.7B | $6.9B |
| Free cash flow | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B | $4.9B | $6.0B | $5.9B | $3.6B | $5.6B |
| Cash & equivalents | $1.9B | $2.2B | $1.3B | $1.5B | $3.7B | $3.6B | $4.1B | $4.4B | $3.7B | $5.0B |
| Inventory | $6.0B | $5.5B | $5.2B | $5.3B | $4.6B | $4.3B | $4.2B | $3.8B | $3.6B | $3.3B |
| Total assets | $93.0B | $91.7B | $90.0B | $90.9B | $91.0B | $93.1B | $90.7B | $89.7B | $91.4B | $99.9B |
| Total liabilities | $43.0B | $43.4B | $39.6B | $39.3B | $38.3B | $41.5B | $39.8B | $39.5B | $40.6B | $49.5B |
| Shareholders' equity | $50.1B | $48.3B | $50.4B | $51.7B | $52.7B | $51.6B | $50.9B | $50.2B | $50.8B | $50.3B |
Growth · year-over-year · Revenue CAGR 2.3%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +8.4% | +3.6% | +3.6% | -1.4% | +5.2% | +4.2% | -5.4% | +2.0% | +0.8% | +3.0% |
| Net income growth | +3.0% | +26.8% | -2.2% | -25.4% | +39.7% | -24.7% | +3.4% | +49.2% | -22.9% | +13.8% |
| EPS growth | +3.3% | +30.8% | -2.1% | -24.4% | +40.2% | -24.9% | +3.8% | +50.2% | -21.5% | +16.5% |
| Free cash flow growth | +4.6% | -0.3% | +13.5% | -23.4% | +22.4% | -18.9% | +2.5% | +62.4% | -35.7% | +34.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-04-24. Facts plus Stocktoria's own computed scores — not investment advice.